Corporate Actions
Material events companies report to the SEC on Form 8-K: mergers, dividends, buybacks, splits, management changes, bankruptcies and more. Enter a ticker for one company's history, or browse the latest across the market.
FibroBiologics (FBLG)
1 8-K filing| Filed | Action | What the filing says | SEC |
|---|---|---|---|
| Feb 23, 2026 |
Shareholder Vote
Item 5.07
|
Submission of Matters to a Vote of Security Holders. FibroBiologics, Inc. (the “Company”) held a Special Meeting of Stockholders on February 20, 2026 (the “Special Meeting”). Proxies for the Special Meeting were…Submission of Matters to a Vote of Security Holders. FibroBiologics, Inc. (the “Company”) held a Special Meeting of Stockholders on February 20, 2026 (the “Special Meeting”). Proxies for the Special Meeting were solicited by the Board of Directors of the Company (the “Board”) pursuant to Section 14(a) of the Securities Exchange Act of 1934, as amended, and there was no solicitation in opposition. At the Special Meeting, shares representing 54,974,113 votes were represented in person or by proxy out of the 99,019,722 votes entitled to be cast as of December 26, 2025, the record date for the Special Meeting. The final votes on the proposals presented at the Special Meeting were as follows: Proposal No. 1 The adoption of an amendment to the Company’s Amended and Restated Certificate of Incorporation, as amended, to effect a reverse stock split of our issued and outstanding common stock and |
Filing 8-K |
Each 8-K is classified by its most significant item; hover an item number for its title. Classification and excerpts are read automatically and can be wrong; the filing on SEC.gov is the authority. For research, not investment advice.